BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1345887)

  • 1. Pharmacology of thermogenic drugs.
    Astrup A; Toubro S; Christensen NJ; Quaade F
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man.
    Astrup A; Toubro S
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S41-3. PubMed ID: 8384179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
    Astrup A; Breum L; Toubro S
    Obes Res; 1995 Nov; 3 Suppl 4():537S-540S. PubMed ID: 8697055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
    Ramsey JJ; Colman RJ; Swick AG; Kemnitz JW
    Am J Clin Nutr; 1998 Jul; 68(1):42-51. PubMed ID: 9665095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.
    Horton TJ; Geissler CA
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):91-7. PubMed ID: 8646257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A; Lundsgaard C
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
    Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F
    Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A; Breum L; Toubro S; Hein P; Quaade F
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.
    Bracale R; Petroni ML; Davinelli S; Bracale U; Scapagnini G; Carruba MO; Nisoli E
    PLoS One; 2014; 9(6):e98244. PubMed ID: 24905629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity.
    Dulloo AG; Miller DS
    Am J Clin Nutr; 1987 Mar; 45(3):564-9. PubMed ID: 3825983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture.
    Dulloo AG; Miller DS
    J Nutr; 1987 Feb; 117(2):383-9. PubMed ID: 3559753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study.
    Astrup A; Toubro S; Cannon S; Hein P; Madsen J
    Metabolism; 1991 Mar; 40(3):323-9. PubMed ID: 2000046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thermogenic properties of ephedrine/methylxanthine mixtures: human studies.
    Dulloo AG; Miller DS
    Int J Obes; 1986; 10(6):467-81. PubMed ID: 3804564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis.
    Dulloo AG
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S35-40. PubMed ID: 8384178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies.
    Dulloo AG; Miller DS
    Am J Clin Nutr; 1986 Mar; 43(3):388-94. PubMed ID: 3953478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S; Astrup AV; Breum L; Quaade F
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
    Toubro S; Astrup A; Breum L; Quaade F
    Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation.
    Astrup A
    Acta Endocrinol Suppl (Copenh); 1986; 278():1-32. PubMed ID: 3464154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral mechanisms of thermogenesis induced by ephedrine and caffeine in brown adipose tissue.
    Dulloo AG; Seydoux J; Girardier L
    Int J Obes; 1991 May; 15(5):317-26. PubMed ID: 1885257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
    Buemann B; Marckmann P; Christensen NJ; Astrup A
    Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.